Antibiotic effects on immune response in malnourished infants
Treatments studied
Part of Immune system & allergy, Infections clinical trials.
This study looks at how antibiotics affect the immune system of malnourished infants with diarrhea. It aims to understand if unnecessary antibiotics might harm the body's ability to fight off infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is under 1 year old
- Your baby currently has diarrhea
- Your baby is already enrolled in the main study (NCT02764918)
- You are willing to provide blood and stool samples
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how well a recommended treatment works for children aged 6 months to 5 years who have diarrhea caused by Shigella bacteria. It aims to find the best way to help children recover faster.
This study tests whether adding the antibiotic azithromycin to standard nutritional care helps young children with severe acute malnutrition recover better. It is for children aged 6 to 59 months in Burkina Faso who have uncomplicated malnutrition and are not currently on antibiotics.
This study tests whether giving a common antibiotic, azithromycin, to newborns with low birth weight can help them grow and stay healthier. It aims to see if this medicine can reduce infections and improve vitality in babies.
This trial tests different ways to help children who have recovered from severe acute malnutrition stay healthy and avoid getting sick again. It compares monthly supplements, medicine, or both to see which works best.
This study tests if giving azithromycin to women and young children in rural Niger can reduce deaths and track antibiotic resistance. It aims to improve child survival in communities where access to healthcare is limited.
This trial tests whether giving a low dose of azithromycin (an antibiotic) can prevent lung infections in young children with structural lung damage or congenital lung/airway malformations. The goal is to reduce infections and keep lungs healthier.
Hear when a new Antibiotic Resistance Prevention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.